BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102. A total of 30 filers reported holding BELLEROPHON THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $162,000 | +44.6% | 465,780 | +100.0% | 0.00% | – |
| Q3 2019 | $112,000 | -19.4% | 232,890 | 0.0% | 0.00% | – |
| Q2 2019 | $139,000 | -8.6% | 232,890 | 0.0% | 0.00% | – |
| Q1 2019 | $152,000 | -59.1% | 232,890 | -50.0% | 0.00% | – |
| Q4 2018 | $372,000 | +67.6% | 465,780 | +126.3% | 0.00% | – |
| Q3 2018 | $222,000 | -55.4% | 205,863 | 0.0% | 0.00% | – |
| Q2 2018 | $498,000 | +66.0% | 205,863 | +42.4% | 0.00% | – |
| Q1 2018 | $300,000 | -19.4% | 144,551 | 0.0% | 0.00% | – |
| Q4 2017 | $372,000 | +81.5% | 144,551 | 0.0% | 0.00% | – |
| Q3 2017 | $205,000 | +6.2% | 144,551 | 0.0% | 0.00% | – |
| Q2 2017 | $193,000 | +1.6% | 144,551 | +12.9% | 0.00% | – |
| Q1 2017 | $190,000 | – | 127,995 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLINSKY STEVEN B | 4,859,885 | $44,614,000 | 20.33% |
| Senator Investment Group LP | 448,679 | $4,119,000 | 0.04% |
| HIGHLAND CAPITAL MANAGEMENT LP | 162,177 | $1,489,000 | 0.03% |
| Baker Brothers Advisors | 350,000 | $3,213,000 | 0.03% |
| Alyeska Investment Group, L.P. | 94,131 | $864,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 30,000 | $275,000 | 0.01% |
| FMR LLC | 1,302,070 | $11,953,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 15,427 | $142,000 | 0.00% |
| BlackRock Investment Management, LLC | 846 | $8,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 17,290 | $159,000 | 0.00% |